Early inhibitory effects of zoledronic acid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein

Journal of Oral and Maxillofacial Surgery

Volumn 72, Issue 1, 2014, Pages 61-66

  Gerard, David A ^a   Carlson, Eric R ^a   Gotcher, Jack E ^a   Pickett, David O ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORBABLE COLLAGEN SPONGE; COLLAGEN SPONGE; INFUSE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SODIUM CHLORIDE; TETRACYCLINE; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ARTICLE; BONE MASS; BONE REMODELING; BONE TURNOVER; CONTROLLED STUDY; DOG; EUTHANASIA; FEMALE; FEMUR; FRACTURE HEALING; MOLAR TOOTH; NONHUMAN; SINGLE DRUG DOSE; TOOTH EXTRACTION; TOOTH SOCKET; TREATMENT DURATION;

ANIMALS; ANTHRAQUINONES; BICUSPID; BONE DENSITY CONSERVATION AGENTS; BONE MORPHOGENETIC PROTEIN 2; BONE REMODELING; COLLAGEN; COLORING AGENTS; DIPHOSPHONATES; DOGS; DRUG CARRIERS; FEMALE; FEMUR; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMIDAZOLES; INJECTIONS, INTRAVENOUS; MOLAR; OSTEOGENESIS; RECOMBINANT PROTEINS; RIBS; TOLONIUM CHLORIDE; TOOTH EXTRACTION; TOOTH SOCKET; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84890567432     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2013.06.192     Document Type: Article

References (33)

1. P. Major The use of zoledronic acid, a novel, highly potent bisphosphonate for the treatment of hypocalcaemia of malignancy Oncologist 7 2002 481
2. A. Lipton, E. Small, and F. Saad The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: A comparison to pamidronate Cancer Invest 20 suppl 2002 45
3. H. Fleisch Zoledronic acid: An evolving role in the treatment of cancer patients with bone disease Semin Oncol 28 2 suppl 2001 45
4. R.G. Russell, J.E. Dunford, and U. Oppermann Bisphosphonates: An update on mechanisms of action and how these relate to clinical efficacy Ann N Y Acad Sci 1117 2007 209
5. D.B. Kimmel Mechanism of action, pharmacokinetic profile, clinical applications of nitrogen containing bisphosphonates J Dent Res 86 2007 1022
6. F. Saad, D.M. Gleason, and R. Murray Zoledronic acid significantly reduces pathologic fractures in patients with advanced-stage prostate cancer metastatic to bone J Natl Cancer Inst 96 2004 879
7. F. Saad, D.M. Gleason, and R. Murray A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma J Natl Cancer Inst 94 2002 1458
8. M.R. Smith Osteoblast targets therapy for prostate cancer: Bisphosphonates and beyond Urol Oncol 26 2008 420
9. R.J. Lee, P.J. Saylor, and M.R. Smith Treatment and prevention of bone complications from prostate carcinoma Bone 48 2011 88
10. R. Aft Protection of bone in premenopausal women with breast cancer: Focus on zoledronic acid Int J Womens Health 4 2012 569
11. J.A. Carter, A.D. Joshi, and S. Kaura Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumors Pharmacoeconomics 30 2012 373
12. B.M. Misof, P. Roschger, and D. Gabriel Annual intravenous zoledronic acid for 3 years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohort J Bone Miner Res 28 2013 442
13. M.C. Winter, and R.E. Coleman Bisphosphonates in the adjuvant treatment of breast cancer Clin Oncol (R Coll Radiol) 25 2013 135
14. M. Clyne Prostate cancer: New light shed on the anticancer effects of zoledronic acid Nat Rev Urol 9 2012 235
15. B.J. Edwards, M. Gounder, and L.M. McKay Pharmacovigilance and reporting oversight in US FDA fast-track process; bisphosphonates and osteonecrosis of the jaw Lancet Oncol 9 2008 1166
16. A.L. Watters, H.J. Hansen, and T. Williams Intravenous bisphosphonate-related osteonecrosis of the jaw; long-term follow-up of 109 patients Oral Surg Oral Med Oral Pathol Oral Radiol 115 2013 192
17. M.R. Urist Bone formation by autoinduction Science 12 1966 693
18. M.R. Urist, and B.S. Strates Bone morphogenetic protein J Dent Res 50 1971 1392
19. D. Chen, M. Zhao, and G.R. Mundy Bone morphogenetic proteins Growth Factors 22 2004 233
20. B. McKay, and H.S. Sandhu Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications Spine 27 suppl 2002 566
21. D.C. Lu, L.M. Tumialan, and D. Chou Multilevel anterior cervical discectomy and fusion with and without rhBMP2: A comparison of dysphagia rates and outcomes in 150 patients J Neurosurg Spine 18 2013 43
22. M. Geiger, R.H. Li, and W. Friess Collagen sponges for bone regeneration with rhBMP-2 Adv Drug Deliv Rev 55 2003 1613
23. A.A. Jones, D. Buser, and R. Schenk The effect of rhBMP2 around endosseous implants with and without membranes in a canine model J Periodontol 77 2006 1184
24. V. Chappuis, L. Gamer, and K. Cox Periosteal BMP2 drives bone graft healing Bone 51 2012 800
25. R. Visser, P.M. Arrabal, and J. Becerra The effect of an rhBMP2 absorbable collagen sponge-targeted system on bone formation in vivo Biomaterials 30 2009 2032
26. S.P. Luckman, D.E. Hughes, and F.P. Coxon Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins including Ras J Bone Miner Res 13 1998 581
27. Y.Y. Yu, S. Lieu, and D. Hu Site specific effects of zoledronic acid during tibial and mandibular repair PloS One 7 2012 e31771
28. U. Tatli, Y. Uston, and M. Korkco Effects of zoledronic acid on healing mandibular fractures: An experimental study in rabbits J Oral Maxillofac Surg 69 2011 1726
29. G. Misso, M. Porru, and A. Stoppacciaro Cancer Biol Ther 1 2012 1491
30. M.R. Allen, D.J. Kubek, and D.B. Burr Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs Osteoporos Int 22 2011 693
31. G. Cardarapoli, M. Araujo, and J. Lindhe Dynamics of bone formation in tooth extraction sites: An experimental study in dogs J Clin Periodontol 30 2003 809
32. H.M. Frost The regional acceleratory phenomenon: A review Henry Ford Hosp Med J 31 1983 3
33. D. Gerard, P. Morris, and J. Gotcher Does AAA bone augmentation enhance fresh extraction site healing? J Dent Res 72 1993 812